You are here

larotrectinib

Loxo Oncology Shares Rally, Despite Diluting Investors

Loxo Oncology Shares Rally, Despite Diluting Investors

Motley Fool

Flag link:

A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us

A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us

Forbes

clinical trials

Flag link:

Loxo takes center stage at ASCO with its groundbreaking shot at a biomarker-based cancer drug approval

Loxo takes center stage at ASCO with its groundbreaking shot at a biomarker-based cancer drug approval

Endpoints

Flag link: